bexarotene has been researched along with ro 13-6298 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auwerx, J; Dallongeville, J; Heyman, RA; Kosykh, V; Schoonjans, K; Staels, B; Vu-Dac, N | 1 |
1 other study(ies) available for bexarotene and ro 13-6298
| Article | Year |
|---|---|
Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Topics: Apolipoprotein A-II; Apolipoproteins E; Base Sequence; Benzoates; Bexarotene; Carcinoma, Hepatocellular; Cloning, Molecular; DNA-Binding Proteins; Female; Gene Expression Regulation; Genomic Library; HeLa Cells; Humans; Kinetics; Liver Neoplasms; Molecular Sequence Data; Nicotinic Acids; Oligodeoxyribonucleotides; Placenta; Pregnancy; Receptors, Retinoic Acid; Regulatory Sequences, Nucleic Acid; Retinoid X Receptors; Retinoids; RNA, Messenger; Tetrahydronaphthalenes; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Tumor Cells, Cultured | 1996 |